TGA Approval

DEPO-RALOVERA medroxyprogesterone acetate 150 mg/1 mL injection vial (44464)

ARTG ID

44464

ARTG Name

DEPO-RALOVERA medroxyprogesterone acetate 150 mg/1 mL injection vial

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

May 31, 1993

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-05413-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-05414-3

Ingredient Name

medroxyprogesterone acetate

Empowering clinical research with data-driven insights and AI-powered tools.

DEPO-RALOVERA medroxyprogesterone acetate 150 mg/1 mL injection vial (44464) - TGA 批准文号 | MedPath